Mashup Score:16
JAMA NetworkDOACs vs LMWH and Recurrent VTE in Patients With Cancer - 2 days
Mashup Score:16
Twitter Feed: Sanjay Kaul
Mashup Score:6
BioSpaceGrail, the blood testing company, explores the potential of its commercial blood test, Galleri, in detecting cancer...
-
https://t.co/Qvogx4zgX8 To put things in perspective, compare performance of GRAIL test for cancer detection with the best we have for CVD detection (CAC score). Is it too good to be true? https://t.co/Qvogx4zgX8 - view on twitter
This randomized trial assesses the comparative effectiveness of direct oral anticoagulants vs low-molecular-weight heparin on rate of 6-month recurrence of venous thromboembolism (VTE) among...
Open-label RCT Noninferiority met for recurrent VTE Mortality: 3.1% ⬆️with DOAC, 95% CI -3.1%-9.3% No difference in major or minor bleeding ⬆️in clinically relevant nonmajor bleeding: 3.2% (0.1%-6.3%) No difference in QoL Should DOAC be preferred agent? https://t.co/3HRyzZ3t2F - view on twitter